23 July,2026 05:11 PM IST | New Delhi | PTI
Representational Image. File pic.
Homegrown pharma major Cipla Ltd on Thursday reported a 39 per cent decline in consolidated net profit at Rs 785.55 crore in the first quarter ended June 2026, dragged by a dip in sales in the North American market and higher expenses.
The company had posted a consolidated net profit of Rs 1,291.61 crore in the corresponding period of the preceding fiscal, Cipla Ltd said in a regulatory filing.
Consolidated total revenue from operations in the first quarter of FY27 stood at Rs 7,119.28 crore as against Rs 6,957.47 crore in the same period a year ago.
Total expenses in the quarter under review increased to Rs 6,248.25 crore, compared to Rs 5,446.1 crore in Q1 FY26, the company said. âÂÂ
Sales in North America were down 21 per cent at Rs 1,532 crore as compared to Rs 1,933 crore in the year-ago period, Cipla said. âÂÂ
One-India business recorded the highest quarterly sales with a growth of 12 per cent at Rs 3,452 crore, compared to Rs 3,070 crore in the same period last fiscal.
Cipla also announced the appointment of Dinesh Jain as its Global Chief Financial Officer from July 24, 2026. âÂÂ
Jain, currently Chief of Corporate Finance, will succeed Ashish Adukia, who is transitioning to an internal business leadership role, Cipla said in a separate regulatory filing. âÂÂ
Jain is a seasoned finance leader with over three decades of experience in strategic planning and corporate finance, including accounting, taxation, treasury, business finance and corporate governance, among others, the company said.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.